Combined fluorometric analysis of biliverdin and bilirubin by the recombinant protein HUG
- PMID: 39430781
- PMCID: PMC11490793
- DOI: 10.1016/j.mex.2024.102979
Combined fluorometric analysis of biliverdin and bilirubin by the recombinant protein HUG
Abstract
Biliverdin is a secondary metabolite of heme catabolism. It is formed by the reaction catalyzed by heme oxygenase, which converts the heme group contained in proteins such as hemoglobin, myoglobin, cytochromes, and catalase into biliverdin, iron (II) and CO in equimolar amounts, consuming NADPH. Biliverdin is then reduced to bilirubin by biliverdin reductase. Biliverdin and bilirubin form a redox couple and are important for the redox homeostasis of cells. Heme oxygenase-1 is an inducible enzyme that is induced by hypoxic conditions, increased availability of heme or proinflammatory mechanisms such as LPS, UV radiation, etc. In addition, both heme oxygenase-1 and biliverdin reductase play roles other than catalysis by modulating specific metabolic pathways at the transcriptional level. There is a need for affordable assays to analyze these bile pigments in biological and clinical samples. Here we present a method for the combined determination of biliverdin and bilirubin that utilizes the specific binding of bilirubin to the fluorescent recombinant fusion protein HUG and the enzymatic conversion of biliverdin to bilirubin.•This method enables the combined measurement of bilirubin and biliverdin in the nM range.•The method does not require solvent extraction or protein precipitation of the samples.
Keywords: Assay optimal parameters; Biliverdin; Biological fluids; Combined biliverdin and bilirubin analysis with HUG; Plasma.
© 2024 The Authors. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures







References
-
- Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase: characterization of the enzyme. J. Biol. Chem. 1969;244(23):6388–6394. - PubMed
-
- Tenhunen R., Ross M.E., Marver H.S., Schmid R. Reduced nicotinamide adenine dinucleotide phosphate dependent biliverdin reductase. Partial purification and characterization. Biochemistry. 1970;9(2):298–303. - PubMed
-
- Barañano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. u S. a. 2002;99(25):16093–16098. 10.1073/PNAS.252626999/ASSET/F8DD06A8-58C2-4A6B-916D-CD04A269B808/ASSETS... - DOI - PMC - PubMed
-
- T. Jansen, A. Daiber, J. Kapitulnik, T. Hebrew, and M.D. Maines, “Direct antioxidant properties of bilirubin and biliverdin. Is there a role for biliverdin reductase?,” 2012, doi: 10.3389/fphar.2012.00030. - DOI - PMC - PubMed
-
- T.W. Sedlak, M. Saleh, D.S. Higginson, B.D. Paul, K.R. Juluri, and S.H. Snyder, “Bilirubin and glutathione have complementary antioxidant and cytoprotective roles,” 2009. [Online]. Available: www.pnas.org/cgi/content/full/ - PMC - PubMed
LinkOut - more resources
Full Text Sources